Table 3.
Case-patients who Reported Consuming OxyELITE Pro™ by Source of Identification and Other Supplement Use — United States, 2013 (n = 25)
| Identified through NPDS or FDA MedWatch n (%) | Identified by DoD, state health department, or CDC Hotline n (%) | Overall n (%) | |
|---|---|---|---|
| Consumed only OxyELITE Pro™ | 3 (23.1) | 4 (33.3) | 7 (28.0) |
| Consumed OxyELITE Pro™ and another supplement | 5 (38.5) | 7 (58.3) | 12 (48.0) |
| Incomplete information on supplement use other than OxyELITE Pro™ | 5 (38.5) | 1 (8.3) | 6 (24.0) |